Cargando…
Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection
Both type 2 diabetes (T2D) and chronic hepatitis C (CHC) infection are associated with increased risk of developing hepatocellular carcinoma (HCC). Cytokines are known to play an important role not only in the mechanisms of insulin resistance and glucose disposal defects but also in the pathological...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379982/ https://www.ncbi.nlm.nih.gov/pubmed/22745767 http://dx.doi.org/10.1371/journal.pone.0039486 |
_version_ | 1782236272988782592 |
---|---|
author | Costantini, Susan Capone, Francesca Guerriero, Eliana Marfella, Raffaele Sorice, Angela Maio, Patrizia Di Stasio, Michele Paolisso, Giuseppe Castello, Giuseppe Colonna, Giovanni |
author_facet | Costantini, Susan Capone, Francesca Guerriero, Eliana Marfella, Raffaele Sorice, Angela Maio, Patrizia Di Stasio, Michele Paolisso, Giuseppe Castello, Giuseppe Colonna, Giovanni |
author_sort | Costantini, Susan |
collection | PubMed |
description | Both type 2 diabetes (T2D) and chronic hepatitis C (CHC) infection are associated with increased risk of developing hepatocellular carcinoma (HCC). Cytokines are known to play an important role not only in the mechanisms of insulin resistance and glucose disposal defects but also in the pathological processes occurring in the liver during viral infection. We evaluated the serum levels of many cytokines, chemokines, adipokines and growth factors in patients with type 2 diabetes, CHC, CHC-related cirrhosis, CHC and type 2 diabetes and CHC-related cirrhosis and type 2 diabetes by BioPlex assay. The obtained data evidenced that the serum levels of some proteins are significantly up-regulated in all the patients or in those with only one disease and are often higher, even if in different amounts, when both diseases are associated. In particular, our results can be useful for the clinical monitoring of patients because they give specific information in regard to the progression from CHC to LC and CHD to LCD. Moreover, some molecules have shown significant correlations with clinical/biochemical data, suggesting the possibility to define mini-panels that can be used as specific markers for the different disease staging. However, our observations demonstrate that an integrated approach is much more powerful than isolated measurements to evaluate specific stages of these two complex pathologies (type 2 diabetes and chronic CHC hepatitis) alone or when they are concomitant in a patient. In fact it has emerged as an accurate, simple, specific, noninvasive, reproducible and less expensive method that, in future, could be included in routine clinical practice to monitor the association of type 2 diabetes and/or CHC to liver cirrhosis and, possibly, to cancer, and to improve the prognosis of these diseases. |
format | Online Article Text |
id | pubmed-3379982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-33799822012-06-28 Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection Costantini, Susan Capone, Francesca Guerriero, Eliana Marfella, Raffaele Sorice, Angela Maio, Patrizia Di Stasio, Michele Paolisso, Giuseppe Castello, Giuseppe Colonna, Giovanni PLoS One Research Article Both type 2 diabetes (T2D) and chronic hepatitis C (CHC) infection are associated with increased risk of developing hepatocellular carcinoma (HCC). Cytokines are known to play an important role not only in the mechanisms of insulin resistance and glucose disposal defects but also in the pathological processes occurring in the liver during viral infection. We evaluated the serum levels of many cytokines, chemokines, adipokines and growth factors in patients with type 2 diabetes, CHC, CHC-related cirrhosis, CHC and type 2 diabetes and CHC-related cirrhosis and type 2 diabetes by BioPlex assay. The obtained data evidenced that the serum levels of some proteins are significantly up-regulated in all the patients or in those with only one disease and are often higher, even if in different amounts, when both diseases are associated. In particular, our results can be useful for the clinical monitoring of patients because they give specific information in regard to the progression from CHC to LC and CHD to LCD. Moreover, some molecules have shown significant correlations with clinical/biochemical data, suggesting the possibility to define mini-panels that can be used as specific markers for the different disease staging. However, our observations demonstrate that an integrated approach is much more powerful than isolated measurements to evaluate specific stages of these two complex pathologies (type 2 diabetes and chronic CHC hepatitis) alone or when they are concomitant in a patient. In fact it has emerged as an accurate, simple, specific, noninvasive, reproducible and less expensive method that, in future, could be included in routine clinical practice to monitor the association of type 2 diabetes and/or CHC to liver cirrhosis and, possibly, to cancer, and to improve the prognosis of these diseases. Public Library of Science 2012-06-20 /pmc/articles/PMC3379982/ /pubmed/22745767 http://dx.doi.org/10.1371/journal.pone.0039486 Text en Costantini et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Costantini, Susan Capone, Francesca Guerriero, Eliana Marfella, Raffaele Sorice, Angela Maio, Patrizia Di Stasio, Michele Paolisso, Giuseppe Castello, Giuseppe Colonna, Giovanni Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection |
title | Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection |
title_full | Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection |
title_fullStr | Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection |
title_full_unstemmed | Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection |
title_short | Cytokinome Profile of Patients with Type 2 Diabetes and/or Chronic Hepatitis C Infection |
title_sort | cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis c infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379982/ https://www.ncbi.nlm.nih.gov/pubmed/22745767 http://dx.doi.org/10.1371/journal.pone.0039486 |
work_keys_str_mv | AT costantinisusan cytokinomeprofileofpatientswithtype2diabetesandorchronichepatitiscinfection AT caponefrancesca cytokinomeprofileofpatientswithtype2diabetesandorchronichepatitiscinfection AT guerrieroeliana cytokinomeprofileofpatientswithtype2diabetesandorchronichepatitiscinfection AT marfellaraffaele cytokinomeprofileofpatientswithtype2diabetesandorchronichepatitiscinfection AT soriceangela cytokinomeprofileofpatientswithtype2diabetesandorchronichepatitiscinfection AT maiopatrizia cytokinomeprofileofpatientswithtype2diabetesandorchronichepatitiscinfection AT distasiomichele cytokinomeprofileofpatientswithtype2diabetesandorchronichepatitiscinfection AT paolissogiuseppe cytokinomeprofileofpatientswithtype2diabetesandorchronichepatitiscinfection AT castellogiuseppe cytokinomeprofileofpatientswithtype2diabetesandorchronichepatitiscinfection AT colonnagiovanni cytokinomeprofileofpatientswithtype2diabetesandorchronichepatitiscinfection |